Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D ROSENBLOOM

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Diabetes Care|May 1, 1981
Comparison of blood glucose testing using reagent strips with and without a meter (Chemstrips bG and Dextrostix/Dextrometer)P Kubilis, A L Rosenbloom, D Lezotte, et al.
Journal of Occupational Health Psychology|February 24, 2001
Changes in general health and musculoskeletal outcomes in the workforce of a hospital undergoing rapid change: a longitudinal studyH S Shannon, C A Woodward, C E Cunningham, et al.
Healthcare Management Forum|October 28, 1999
Determinants of job stress and job satisfaction among supervisory and non-supervisory employees in a large Canadian teaching hospitalJ A Brown, C A Woodward, H S Shannon, et al.
Clinical Rheumatology|December 1, 1987
Effects of aspirin, naloxone and placeboA A Mewa, D Rosenbloom, E M Grace, et al.
The New England Journal of Medicine|November 4, 1993
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantationR Hull, G Raskob, G Pineo, et al.
Journal of Proteome Research|September 2, 2017
Comparative Proteomics Enables Identification of Nonannotated Cold Shock Proteins in E. coliNadia G D'Lima, Alexandra Khitun, Aaron D Rosenbloom, et al.
The New England Journal of Medicine|May 3, 1990
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspectiveR D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine|August 1, 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveR D Hull, G E Raskob, D Rosenbloom, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Diabetes Care|May 1, 1981
Comparison of blood glucose testing using reagent strips with and without a meter (Chemstrips bG and Dextrostix/Dextrometer)P Kubilis, A L Rosenbloom, D Lezotte, et al.
Journal of Occupational Health Psychology|February 24, 2001
Changes in general health and musculoskeletal outcomes in the workforce of a hospital undergoing rapid change: a longitudinal studyH S Shannon, C A Woodward, C E Cunningham, et al.
Healthcare Management Forum|October 28, 1999
Determinants of job stress and job satisfaction among supervisory and non-supervisory employees in a large Canadian teaching hospitalJ A Brown, C A Woodward, H S Shannon, et al.
Clinical Rheumatology|December 1, 1987
Effects of aspirin, naloxone and placeboA A Mewa, D Rosenbloom, E M Grace, et al.
The New England Journal of Medicine|November 4, 1993
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantationR Hull, G Raskob, G Pineo, et al.
Journal of Proteome Research|September 2, 2017
Comparative Proteomics Enables Identification of Nonannotated Cold Shock Proteins in E. coliNadia G D'Lima, Alexandra Khitun, Aaron D Rosenbloom, et al.
The New England Journal of Medicine|May 3, 1990
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspectiveR D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine|August 1, 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveR D Hull, G E Raskob, D Rosenbloom, et al.
Pageof 5